Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Crit Care Med. 2011 Apr;39(4):872-4. doi: 10.1097/CCM.0b013e318208eddf.
Demonstrate a case report involving successful use of lipid emulsion therapy for intractable cardiac arrest due to lidocaine toxicity.
Lipid emulsion therapy has been shown to be effective in treating the cardiotoxic effects of such drugs as bupivacaine, verapamil, propranolol, and clomipramine as mentioned in a 2009 editorial in Critical Care Medicine by Jeffrey Bent. The mechanism of action of lipid emulsion therapy is not well defined and has been postulated to work by both a "lipid sink," decreasing circulating amounts of drugs to the periphery, or through a direct "energy source" to the myocardium. We present a case report of a patient successfully resuscitated with lipid emulsion therapy after prolonged and intractable lidocaine toxicity. Lidocaine is generally considered much less cardiotoxic than other local anesthetics and is used commonly as infusions for intractable ventricular arrhythmias.
This case demonstrates the need to consider lipid emulsion therapy in the advanced cardiac life support algorithm for lidocaine toxicity as well as other lipid soluble drug intoxications.
报告 1 例成功应用脂肪乳剂治疗利多卡因中毒致顽固性心脏骤停的病例。
2009 年《危重病医学》杂志上 Jeffrey Bent 的一篇社论中提到,脂肪乳剂治疗已被证明可有效治疗布比卡因、维拉帕米、普萘洛尔和氯米帕明等药物的心脏毒性。脂肪乳剂治疗的作用机制尚不清楚,据推测,其作用机制既可以是“脂质清除剂”,减少药物向周围循环的释放,也可以是通过直接向心肌提供“能量源”。我们报告了 1 例利多卡因中毒患者经脂肪乳剂治疗成功复苏的病例。利多卡因通常被认为比其他局部麻醉药的心脏毒性小,并且常被用作治疗顽固性室性心律失常的输注药物。
本病例表明,在利多卡因毒性以及其他脂溶性药物中毒的高级心脏生命支持算法中,需要考虑脂肪乳剂治疗。